OXLUMO

Serial Number 88352142
Registration 6295911
700

Registration Progress

Application Filed
Mar 22, 2019
Under Examination
Sep 10, 2019
Approved for Publication
Jul 16, 2019
Published for Opposition
Jul 16, 2019
Registered
Mar 16, 2021

Basic Information

Serial Number
88352142
Registration Number
6295911
Filing Date
March 22, 2019
Registration Date
March 16, 2021
Published for Opposition
July 16, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 16, 2021
Registration
Registered
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Timothy H. Hiebert

USPTO Deadlines

Next Renewal Deadline
616 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-03-16)
Due Date
March 16, 2027
Grace Period Ends
September 16, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description
Mar 16, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Feb 11, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 10, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 24, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jan 24, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 5, 2021 EISU I TEAS STATEMENT OF USE RECEIVED
Jan 5, 2021 IUAF S USE AMENDMENT FILED
Sep 4, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 2, 2020 EX2G S SOU EXTENSION 2 GRANTED
Sep 2, 2020 EXT2 S SOU EXTENSION 2 FILED
Sep 2, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 14, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 14, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 14, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 5, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2020 EX1G S SOU EXTENSION 1 GRANTED
Mar 3, 2020 EXT1 S SOU EXTENSION 1 FILED
Mar 3, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 10, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 16, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2019 PUBO A PUBLISHED FOR OPPOSITION
Jun 26, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 4, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 3, 2019 DOCK D ASSIGNED TO EXAMINER
Apr 9, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2019 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of primary hyperoxaluria
First Use Anywhere: Dec 17, 2020
First Use in Commerce: Dec 17, 2020

Additional Information

Translation
The wording "OXLUMO" has no meaning in a foreign language.

Classification

International Classes
005